Repeat CT for evaluation of inter- and intrafraction changes during curative thoracic radiotherapy; An exploratory pilot study.

Repeat CT for evaluation of inter- and intrafraction changes during curative thoracic radiotherapy; An exploratory pilot study. - REACT-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43004

Enrollment

Registered

2016-09-23

Start date

2016-12-08

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(non) small cell lung cancer stage 3 breast cancer or (non) Hodgkin lymphoma Patients with esophageal cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Histologically proven esophageal cancer, stage III NSCLC or SCLC, breast cancer, or (non) Hodgkin lymphoma. - Scheduled for external-beam photon radiotherapy to the thoracic region with curative intention. - Scheduled for (neo-)adjuvant or primary (chemo)radiotherapy. - WHO 0-2. - Age >= 18 years. - Written informed consent.

Exclusion criteria

Exclusion criteria: - Relative contra-indications, such as pain, for lying on the treatment or CT couch. - Non compliance with any of the inclusion criteria.

Design outcomes

Primary

Measure	Time frame
Dose coverage of the target volumes (CTVs).	—

Secondary

Measure	Time frame
• Margin for inter-fraction variation (in relation to the ITV and PTV margin) • Areas of under dosage • Areas of over dosage • DVH parameters of the heart (MHD, V5, V10, V20, V30, V40, V50, V60) • DVH parameters of the lungs (MLD, V5, V10, V20, V30, V40, V50, V60)	—

Countries

Netherlands

Outcome results